SCHEMBL28983497

SCHEMBL28983497

CC(C)(C)c1cn(C(=O)O)nc1Oc1ccc(NC(=O)OCc2ccccc2)c(F)c1

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ P2RY1 P47900 6/20 0.40
▸ HRH3 Q9Y5N1 1/20 0.39
▸ KDR P35968 3/20 0.39
▸ FLT1 P17948 1/20 0.39
▸ FLT4 P35916 1/20 0.39
▸ TACR3 P29371 1/20 0.39
▸ FAAH O00519 1/20 0.39
▸ MGLL Q99685 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ PTGDR2 Q9Y5Y4 1/20 0.37
▸ ELANE P08246 1/20 0.37
▸ MGAT2 Q10469 1/20 0.36
▸ BRAF P15056 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23355358 0.79 NPC1 (0.45) NPC1RAB9AHRH3TACR3FAAH
SCHEMBL21612828 0.76 NPC1 (0.43) NPC1RAB9AHRH3TACR3FAAH
SCHEMBL14050311 0.73 NPC1 (0.49) NPC1RAB9AHRH3KDRFLT1
SCHEMBL30203116 0.72 NPC1 (0.47) NPC1RAB9AHRH3TACR3MGLL
SCHEMBL23368156 0.72 NPC1 (0.47) NPC1RAB9AHRH3TACR3MGLL
SCHEMBL12992722 0.72 MAPK14 (0.48) NPC1RAB9AKDRBRAF
SCHEMBL2635340 0.72 RAB9A (0.54) NPC1RAB9AHRH3TACR3MGLL
SCHEMBL1726533 0.71 NPC1 (0.43) NPC1RAB9AKDRFLT1TACR3
SCHEMBL1727470 0.71 NPC1 (0.47) NPC1RAB9AKDRFLT1FLT4
SCHEMBL12992197 0.71 MAPK14 (0.52) NPC1RAB9AKDRFLT1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115803326-B EGFR inhibitor, preparation method thereof and application thereof in pharmacy 上海和誉生物医药科技有限公司 2024-03-26 — — CN disclosed
CN-115803326-A EGFR inhibitor, preparation method and pharmaceutical application thereof 上海和誉生物医药科技有限公司 2023-03-14 — — CN disclosed
Send feedback